Systems Offer Effective, Minimally Invasive Treatment Options for Millions of Patients with Obesity (BMI 30-50 kg/m2)AUSTIN, TX / ACCESSWIRE / July 13, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN)
acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.
DGAP-News: Apollo Endosurgery, Inc. / Key word(s): Legal Matter FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity 13.07.2022 / 07:30 The issuer is solely responsible for the content of this .
13.07.2022 - DGAP-News: Apollo Endosurgery, Inc. / Key word(s): Legal Matter FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity 13.07.2022 / 07:30 The . Seite 1